Free Trial

Playtika (PLTK) Competitors

Playtika logo
$7.91
+0.08 (+1.02%)
(As of 11/1/2024 ET)

PLTK vs. ULS, MEDP, GLOB, STN, BILI, HQY, MPLN, QXO, ETSY, and LYFT

Should you be buying Playtika stock or one of its competitors? The main competitors of Playtika include UL Solutions (ULS), Medpace (MEDP), Globant (GLOB), Stantec (STN), Bilibili (BILI), HealthEquity (HQY), MultiPlan (MPLN), QXO (QXO), Etsy (ETSY), and Lyft (LYFT). These companies are all part of the "business services" industry.

Playtika vs.

Playtika (NASDAQ:PLTK) and UL Solutions (NYSE:ULS) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment, valuation, dividends and community ranking.

Playtika pays an annual dividend of $0.40 per share and has a dividend yield of 5.1%. UL Solutions pays an annual dividend of $0.50 per share and has a dividend yield of 1.0%. Playtika pays out 70.2% of its earnings in the form of a dividend.

Playtika has a net margin of 8.44% compared to UL Solutions' net margin of 0.00%. UL Solutions' return on equity of 0.00% beat Playtika's return on equity.

Company Net Margins Return on Equity Return on Assets
Playtika8.44% -127.12% 8.12%
UL Solutions N/A N/A N/A

In the previous week, UL Solutions had 3 more articles in the media than Playtika. MarketBeat recorded 6 mentions for UL Solutions and 3 mentions for Playtika. UL Solutions' average media sentiment score of 1.29 beat Playtika's score of 0.33 indicating that UL Solutions is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Playtika
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
UL Solutions
4 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

UL Solutions has higher revenue and earnings than Playtika.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Playtika$2.57B1.15$235M$0.5713.88
UL Solutions$2.68B3.85$260MN/AN/A

Playtika received 33 more outperform votes than UL Solutions when rated by MarketBeat users. However, 71.43% of users gave UL Solutions an outperform vote while only 47.06% of users gave Playtika an outperform vote.

CompanyUnderperformOutperform
PlaytikaOutperform Votes
48
47.06%
Underperform Votes
54
52.94%
UL SolutionsOutperform Votes
15
71.43%
Underperform Votes
6
28.57%

11.9% of Playtika shares are held by institutional investors. 4.8% of Playtika shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Playtika presently has a consensus price target of $9.29, indicating a potential upside of 17.47%. UL Solutions has a consensus price target of $45.80, indicating a potential downside of 11.24%. Given Playtika's higher possible upside, equities analysts clearly believe Playtika is more favorable than UL Solutions.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Playtika
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.25
UL Solutions
0 Sell rating(s)
4 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.67

Summary

UL Solutions beats Playtika on 10 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PLTK vs. The Competition

MetricPlaytikaData processing & preparation IndustryDiscretionary SectorNASDAQ Exchange
Market Cap$2.94B$3.91B$8.13B$8.52B
Dividend Yield5.04%3.06%2.72%4.13%
P/E Ratio13.8827.2816.7615.83
Price / Sales1.154.867.8292.35
Price / Cash6.6125.3833.7434.18
Price / Book-13.185.255.435.07
Net Income$235M$38.86M$262.99M$225.38M
7 Day Performance3.67%-0.44%-0.17%0.06%
1 Month Performance2.59%3.85%1.90%3.93%
1 Year Performance-5.04%9.11%65.30%32.51%

Playtika Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PLTK
Playtika
2.9718 of 5 stars
$7.91
+1.0%
$9.29
+17.5%
-5.0%$2.94B$2.57B13.883,600Upcoming Earnings
News Coverage
ULS
UL Solutions
1.8133 of 5 stars
$52.97
+0.1%
$45.80
-13.5%
N/A$10.59B$2.76B0.0015,233Upcoming Earnings
Positive News
MEDP
Medpace
4.8961 of 5 stars
$330.22
+0.7%
$380.00
+15.1%
+27.0%$10.24B$1.89B28.925,900
GLOB
Globant
4.3277 of 5 stars
$218.04
-0.5%
$224.00
+2.7%
+23.8%$9.43B$2.10B56.9329,150Analyst Forecast
News Coverage
STN
Stantec
3.7267 of 5 stars
$81.78
-0.2%
N/A+31.6%$9.33B$6.91B36.5128,000Upcoming Earnings
Analyst Revision
News Coverage
BILI
Bilibili
1.7341 of 5 stars
$20.65
+3.5%
$18.15
-12.1%
+65.9%$8.53B$23.95B-15.418,801
HQY
HealthEquity
3.7065 of 5 stars
$88.07
+0.6%
$103.83
+17.9%
+26.8%$7.69B$999.59M73.393,150Positive News
MPLN
MultiPlan
2.9067 of 5 stars
$9.69
-1.1%
$25.00
+158.0%
N/A$6.25B$954.92M-0.132,800Upcoming Earnings
QXO
QXO
1.0569 of 5 stars
$15.09
+1.4%
N/AN/A$6.18B$57.11M-1.23195News Coverage
ETSY
Etsy
4.2834 of 5 stars
$48.64
+0.0%
$66.83
+37.4%
-13.0%$5.66B$2.75B22.622,420Earnings Report
Analyst Forecast
Buyback Announcement
Options Volume
Analyst Revision
News Coverage
LYFT
Lyft
4.142 of 5 stars
$13.41
-2.7%
$15.59
+16.3%
+47.0%$5.50B$4.40B-83.812,945Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:PLTK) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners